BRIEF-Amarin up 20.1 percent premarket; FDA delays decision on wider use approval for vascepa drug

NEW YORK Fri Dec 20, 2013 8:02am EST

NEW YORK Dec 20 (Reuters) - Amarin Corporation PLC : * Amarin Corp up 20.1 percent to $1.91 in premarket; FDA delays decision on wider use approval for vascepa drug

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.